Cash Ratio Analysis of Eagle Pharmaceuticals Inc - Deep Dive


Cash Ratio of EGRX
Dec-22
0.498
Poor Cash Ratio
Dec-21
1.31
Indecisive Cash Ratio
Growth
-62.07
%
Cash Ratio Analysis of Eagle Pharmaceuticals Inc
Cash Ratio of Eagle Pharmaceuticals Inc with value of 0.498 indicates that a company has generated low cash in a period than what is needed to pay off its current liabilities.
Cash Ratio of EGRX drastically fell by -62.07 % this year.
Cash Ratio with value of 2.83 was highest in Year Dec-19 in last Five Years.
Cash Ratio of EGRX trending down for at least three Years.
Latest Cash Ratio with value of 0.498 is lower than Average Cash Ratio of 1.87 in last five years.
Other Cash Ratio Related Info of EGRX that may interest you.
Eagle Pharmaceuticals Inc Overview
CodePricePrevious PricePrice ChangeSector
EGRX4.063.85 5.45 % Drug Manufacturers-Specialty & Generic
Fundamental AnalysisTechnical Analysis
Defination of Cash Ratio
The Cash Ratio measures the liquidity position of the company. This metric indicates how much the company can cover its current liabilities by its cash and cash equivalents.   more ..
Cash Ratio Formula

Cash Ratio Related Ratios
CurrentRatioQuickRatioDebtToEquityRatio

Tsr Stability Index
Good Stability
FY - Historical Cash Ratio of Eagle Pharmaceuticals Inc
PeriodDec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16
Cash Ratio0.4981.312.712.831.992.421.29
Change-62.07 %-51.52 %-4.21 %42.42 %-18.09 %87.99 %-44.14 %
You are view first 7 Records. Log in to view all 11 in Premium view
FY Chart of Cash Ratio of Eagle Pharmaceuticals Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)